Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5266 to 5280 of 8314 results

  1. Idiopathic sudden sensorineural hearing loss:- What is the most effective route of administration of steroids as a first-line treatment for idiopathic sudden sensorineural hearing loss?

    Recommendation ID NG98/1 Question Idiopathic sudden sensorineural hearing loss:- What is the most effective route of administration of

    Research recommendation
    Published
    10 December 2018

  2. Timing of first health visitor visit: What is the most effective timing of the first postnatal contact by a health visitor?

    Recommendation ID NG194/2 Question Timing of first health visitor visit: What is the most effective timing of the first postnatal contact

    Research recommendation
    Published
    6 August 2021

  3. Postpartum haemorrhage: What is the most effective treatment for primary postpartum haemorrhage?

    Recommendation ID CG190/05 Question Postpartum haemorrhage: What is the most effective treatment for primary postpartum haemorrhage?

    Research recommendation
    Published
    6 January 2023

  4. What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs) compared with a standard prophylactic dose for venous thromboembolism (VTE) prophylaxis in young people under 18 years with COVID-19?

    Recommendation ID NG191/3 Question What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs)

    Research recommendation
    Published
    10 August 2021

  5. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    Recommendation ID NG191/2 Question What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis

    Research recommendation
    Published
    10 August 2021

  6. What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2 variants?

    Recommendation ID NG191/15 Question What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2

    Research recommendation
    Published
    9 March 2022

  7. What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological venous thromboembolism (VTE) prophylaxis for people with COVID-19, with or without additional risk factors for VTE?

    Recommendation ID NG191/1 Question What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological

    Research recommendation
    Published
    10 August 2021

  8. Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability of advocacy as a means of supporting people to make decisions?

    Recommendation ID NG108/3 Question Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability

    Research recommendation
    Published
    18 December 2018

  9. Dementia education and training programmes for family members and carers:- What is the effectiveness, cost effectiveness and acceptability of training programmes (forexample, in the use of life story work) for families of people growing older with learning disabilities who have dementia or are at risk of developing it?

    Recommendation ID NG96/4 Question Dementia education and training programmes for family members and carers:- What is the effectiveness

    Research recommendation
    Published
    29 November 2018

  10. Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention to treat people on haemodialysis with ESA‑resistant anaemia?

    Recommendation ID NG203/23 Question Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention

    Research recommendation
    Published
    30 September 2021

  11. What is the most effective way to monitor and evaluate community-wide approaches to obesity to ensure: 1) evidence of effectiveness is gathered across the breadth of the local system and 2) data are produced to help local communities adapt and improve their approach?

    Recommendation ID PH42/1 Question What is the most effective way to monitor and evaluate community-wide approaches to obesity to ensure:

    Research recommendation
    Published
    9 June 2015

  12. How to provide pelvic floor muscle training: What is the most effective way to provide pelvic floor muscle training (covering the type of training, the timing, and who should supervise it), to improve adherence and prevent pelvic floor dysfunction?

    Recommendation ID NG210/01 Question How to provide pelvic floor muscle training: What is the most effective way to provide pelvic floor

    Research recommendation
    Published
    7 January 2022

  13. In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal urinary antigen testing in addition to other routine tests improve outcomes?

    Recommendation ID CG191/1 Question In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal urinary

    Research recommendation
    Published
    9 June 2015

  14. What is the clinical and cost effectiveness of inpatient rehabilitation provided by the independent sector compared with that provided by the NHS?

    Recommendation ID NG181/5 Question What is the clinical and cost effectiveness of inpatient rehabilitation provided by the independent

    Research recommendation
    Published
    26 October 2020

  15. In patients hospitalised with moderate- to high-severity community-acquired pneumonia, does using C-reactive protein monitoring in addition to clinical observation to guide antibiotic duration safely reduce the total duration of antibiotic therapy compared with a fixed empirical antibiotic course?

    Recommendation ID CG191/2 Question In patients hospitalised with moderate- to high-severity community-acquired pneumonia, does using C-reactive

    Research recommendation
    Published
    9 June 2015